Intake of B6, B9, and B12 was quantified from 2 or more dietary recall questionnaires from the UK Biobank and compared to glaucoma-relevant outcomes. Intake of 1.64–1.99 mg of B6 (Q2) or 247.2–302.5 g (Q2) and 302.5–366.3 g (Q3) of B9 was associated with significantly thicker mRNFL (p< 0.05, red; p> 0.05, dark gray; for mRNFL, n= 2,907 people for Q1, n= 2,995 for Q2, n= 2,879 for Q3, n= 2,990 for Q4; for GCIPL, n= 2,897 people for Q1, n= 2,995 for Q2, n= 2,880 for Q3, n= 2,979 for Q4; for glaucoma odds, n= 6,677 people for Q1, n= 6,803 for Q2, n= 6,697 for Q3, n= 7,014 for Q4). Also see Table S6.
